Tri-Heal (45 mg Vial) Dosage Protocol
Quickstart Highlights
Tri-Heal is a research peptide blend combining TB-500 (25 mg), BPC-157 (10 mg), and KPV (10 mg) for advanced tissue repair and inflammation modulation[1]. TB-500 is a synthetic fragment of thymosin β4, a 43-amino-acid peptide involved in cell migration, angiogenesis, and wound healing[2]. BPC-157 is a synthetic 15-amino-acid body protection compound with pro-angiogenic and gastroprotective properties[3]. KPV (Lys-Pro-Val) is a tripeptide derived from α-MSH noted for potent anti-inflammatory effects[4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard 8-Week Protocol (3 mL = 15 mg/mL)
| Week | Daily Dose (mcg) | Daily Dose (mg) | Units (per injection) | Volume (mL) |
|---|---|---|---|---|
| Weeks 1–2 | 500 mcg | 0.5 mg | 3.3 units* | 0.033 mL |
| Weeks 3–4 | 1000 mcg | 1.0 mg | 6.7 units* | 0.067 mL |
| Weeks 5–6 | 1500 mcg | 1.5 mg | 10 units | 0.10 mL |
| Weeks 7–8 | 2000 mcg | 2.0 mg | 13.3 units | 0.133 mL |
*Precision Note: For doses ≤10 units (≤0.10 mL), consider using 30-unit or 50-unit insulin syringes for improved readability and accuracy.
Frequency: Inject once daily subcutaneously[6]. This schedule uses the largest practical dilution (3.0 mL) to optimize syringe accuracy across all dose levels.
Extended 12-Week Protocol (3 mL = 15 mg/mL)
| Week | Daily Dose (mcg) | Daily Dose (mg) | Units (per injection) | Volume (mL) |
|---|---|---|---|---|
| Weeks 1–2 | 500 mcg | 0.5 mg | 3.3 units* | 0.033 mL |
| Weeks 3–4 | 1000 mcg | 1.0 mg | 6.7 units* | 0.067 mL |
| Weeks 5–6 | 1500 mcg | 1.5 mg | 10 units | 0.10 mL |
| Weeks 7–8 | 2000 mcg | 2.0 mg | 13.3 units | 0.133 mL |
| Weeks 9–10 | 2500 mcg | 2.5 mg | 16.7 units | 0.167 mL |
| Weeks 11–12 | 3000 mcg | 3.0 mg | 20 units | 0.20 mL |
Extended 16-Week Protocol (3 mL = 15 mg/mL)
| Week | Daily Dose (mcg) | Daily Dose (mg) | Units (per injection) | Volume (mL) |
|---|---|---|---|---|
| Weeks 1–2 | 500 mcg | 0.5 mg | 3.3 units* | 0.033 mL |
| Weeks 3–4 | 1000 mcg | 1.0 mg | 6.7 units* | 0.067 mL |
| Weeks 5–6 | 1500 mcg | 1.5 mg | 10 units | 0.10 mL |
| Weeks 7–8 | 2000 mcg | 2.0 mg | 13.3 units | 0.133 mL |
| Weeks 9–10 | 2500 mcg | 2.5 mg | 16.7 units | 0.167 mL |
| Weeks 11–12 | 3000 mcg | 3.0 mg | 20 units | 0.20 mL |
| Weeks 13–14 | 3500 mcg | 3.5 mg | 23.3 units | 0.233 mL |
| Weeks 15–16 | 4000 mcg | 4.0 mg | 26.7 units | 0.267 mL |
Reconstitution Steps
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
- 8 weeks (56 doses, ~70 mg total): 2 vials
- 12 weeks (84 doses, ~147 mg total): 4 vials
- 16 weeks (112 doses, ~252 mg total): 6 vials
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
Recommendation: Include 30-unit or 50-unit syringes for the early low-dose phases (Weeks 1–4) where precision is critical.
- 8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
- 12 weeks (4 vials): 12 mL → 2 × 10 mL bottles
- 16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
Concise summary of the once-daily regimen.